FMS-like tyrosine kinase 3 ligand treatment of mice aggravates acute lung injury in response to Streptococcus pneumoniae: Role of pneumolysin

Infection and Immunity

Volumn 80, Issue 12, 2012, Pages 4281-4290

  Brumshagen, Christina ^a   Maus, Regina ^a   Bischof, Andrea ^a   Ueberberg, Bianca ^a   Bohling, Jennifer ^a   Osterholzer, John J ^b   Ogunniyi, Abiodun D ^c   Paton, James C ^c   Welte, Tobias ^a   Mausa, Ulrich A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD11B ANTIGEN; FLT3 LIGAND; PNEUMOLYSIN;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNITY; IMMUNOPHENOTYPING; LUNG LAVAGE; LUNG PROTECTIVE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ACUTE LUNG INJURY; ANIMALS; ANTIGENS, CD11B; BACTERIAL PROTEINS; DENDRITIC CELLS; HUMANS; INFLAMMATION; LIGANDS; LUNG; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 84870849127     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00854-12     Document Type: Article

References (54)

1. +T lymphocyte responses. J. Immunol.172:3725-3735.
2. Barnard Z, et al. 2012. Expression of FMS-like tyrosine kinase 3 ligand by oncolytic herpes simplex virus type I prolongs survival in mice bearing established syngeneic intracranial malignant glioma. Neurosurgery 71:741-748.
3. high dendritic cells in homeostasis and in allergic lung inflammation. J. Immunol. 178:1882-1895.
4. Bohannon J, et al. 2008. Prophylactic treatment with FMS-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection. J. Immunol. 180:3038-3048.
5. Braun JS, Novak R, Gao G, Murray PJ, Shenep JL. 1999. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect. Immun. 67:3750-3756.
6. Briles DE, et al. 2003. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J. Infect. Dis. 188:339-348.
7. Buza-Vidas N, et al.2007. Crucial role of FLT3 ligand in immune reconstitution after bone marrow transplantation and high-dose chemotherapy. Blood 110:424-432.
8. + pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 208:1789-1797.
9. Farley KS, et al. 2006. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol.290:L1164-1172.
10. Fogg DK, et al. 2006. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311:83-87.
11. Fong L, et al. 2001. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. U. S. A. 98:8809-8814.
12. Garvey EP, et al. 1997. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272:4959-4963.
13. Gasparetto C, et al. 2002. Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF. Cytokine 18:8-19.
14. Gilbert RJ, et al. 1999. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 97:647-655.
15. +DCs. J. Exp. Med. 206:3115-3130.
16. Guilliams M, et al. 2009. IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J. Immunol. 182:1107-1118.
17. Hahn I, et al. 2011. Cathepsin G and neutrophil elastase play critical and non-redundant roles in lung protective immunity against Streptococcus pneumoniae in mice. Infect. Immun. 79:4893-4901.
18. Hahn I, et al. 2011. Dendritic cell depletion and repopulation in the lung after irradiation and bone marrow transplantation in mice. Am. J. Respir. Cell Mol. Biol. 45:534-541.
19. Harvey RM, Ogunniyi AD, Chen AY, Paton JC. 2011. Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. Infect. Immun. 79:4122-4130.
20. Henken S, et al. 2010. Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniae. Antimicrob. Agents Chemother. 54:707-717.
21. Henken S, et al. 2010. Evaluation of biophotonic imaging to estimate bacterial burden in mice infected with highly virulent compared to less virulent Streptococcus pneumoniae serotypes. Antimicrob. Agents Chemother.54:3155-3160.
22. + dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC Class I for presentation to CD8 T Cells. J. Immunol. 187:6011-6021.
23. Holt PG. 2005. Pulmonary dendritic cells in local immunity to inert and pathogenic antigens in the respiratory tract. Proc. Am. Thorac. Soc.2:116-120.
24. Kataoka K, et al. 2011. The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia. Infect. Immun. 79:2819-2828.
25. Kingston D, et al. 2009. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 114:835-843.
26. Kirkham LA, et al. 2006. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect. Immun. 74:586-593.
27. Kristof AS, Goldberg P, Laubach V, Hussain SN. 1998. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am. J. Respir. Crit. Care Med. 158:1883-1889.
28. Laubach VE, Shesely EG, Smithies O, Sherman PA. 1995. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharideinduced death. Proc. Natl. Acad. Sci. U. S. A. 92:10688-10692.
29. + monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J. Immunol.180:2562-2572.
30. Liu K, Nussenzweig MC. 2010. Origin and development of dendritic cells. Immunol. Rev. 234:45-54.
31. -δδCT method. Methods 25:402-408.
32. Lucas R, et al. 10 May 2012. Protein kinase C-α and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability. Am. J.Respir. Cell Mol. Biol. doi:10.1165/rcmb.2011-0332OC.
33. Lyman SD, et al. 1993. Molecular cloning of a ligand for the Flt3/Flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 75:1157-1167.
34. Lynch DH, et al. 1997. Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat. Med. 3:625-631.
35. Malley R, et al. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U. S. A. 100:1966-1971.
36. Maraskovsky E, et al. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953-1962.
37. Masten BJ, Olson GK, Kusewitt DF, Lipscomb MF. 2004. Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice. J. Immunol. 172:4077-4083.
38. Maus UA, et al. 2004. Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. J. Immunol. 173:1307-1312.
39. McKenna HJ, et al. 2000. Mice lacking Flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95:3489-3497.
40. Morse MA, et al. 2000. Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer. J. Clin. Oncol. 18:3883-3893.
41. high monocytes. J. Immunol. 183:8044-8053.
42. Rubins JB, et al. 1993. Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect. Immun. 61:1352-1358.
43. Singh P, et al. 2012. Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells. Blood 119:1671-1682.
44. Srivastava M, et al. 2007. Mediator responses of alveolar macrophages and kinetics of mononuclear phagocyte subset recruitment during acute primary and secondary mycobacterial infections in the lungs of mice. Cell Microbiol. 9:738-752.
45. Steinwede K, et al. 2011. Local delivery of GM-CSF protects mice from lethal pneumococcal pneumonia. J. Immunol. 187:5346-5356.
46. 7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176:2161-2172.
47. Taut K, et al. 2008. Macrophage turnover kinetics in the lungs of mice infected with Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol.38:105-113.
48. Triccas JA, et al. 2007. Effects of DNA-and Mycobacterium bovis BCGbased delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis. Infect. Immun. 75:5368-5375.
49. von Wulffen W, et al. 2007. Lung dendritic cells elicited by FMS-like tyrosine 3-kinase ligand amplify the lung inflammatory response to lipopolysaccharide. Am. J. Respir. Crit. Care Med. 176:892-901.
50. Wang LF, et al. 2002. Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am. J. Respir. Crit. Care Med. 165:1634-1639.
51. Weber M, et al. 2012. Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia. FASEB J.26:2424-2436.
52. Wilkins-Rodriguez AA, Escalona-Montano AR, Aguirre-Garcia M, Becker I, Gutierrez-Kobeh L. 2010. Regulation of the expression of nitric oxide synthase by Leishmania mexicana amastigotes in murine dendritic cells. Exp. Parasitol. 126:426-434.
53. Winter C, et al. 2007. FMS-like tyrosine kinase 3 ligand aggravates the lung inflammatory response to Streptococcus pneumoniae infection in mice: role of dendritic cells. J. Immunol. 179:3099-3108.
54. Zhu S, Ware LB, Geiser T, Matthay MA, Matalon S. 2001. Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am. J. Respir. Crit. Care Med.163:166-172.